<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In general, the results of the studies indicated that EOs and/or their compounds presented pharmacological properties through the blockade of mitogen-activated protein kinase (MAPK) pathways, blocking NF-
 <italic class="italic">Îº</italic>B activation by mechanisms associated with the reduction of oxidative stress, leading to the reduction in the production of several proinflammatory mediators (
 <xref ref-type="fig" rid="fig6" class="xref">Figure 6</xref>).
</p>
